[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100628706":3},{"organization":4,"outcomesModule":7,"designInfo":14,"detailedDescription":17,"studyPopulation":18,"armGroups":13,"interventions":13,"overallOfficials":13,"centralContacts":13,"locations":19,"responsibleParty":43,"collaborators":13,"id":47,"slug":48,"hasResults":49,"nctId":50,"briefTitle":51,"officialTitle":52,"acronym":53,"eligibilityCriteria":54,"healthyVolunteers":49,"sex":55,"minAge":56,"maxAge":13,"enrollmentInfo":57,"targetDuration":13,"studyType":60,"phases":13,"briefSummary":61,"conditions":62,"keywords":65,"overallStatus":69,"whyStopped":13,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":74,"completionDateStruct":76,"leadSponsor":78,"locationsCount":79},{"fullName":5,"class":6},"Helios University Hospital Wuppertal","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":13},[9],{"measure":10,"description":11,"timeFrame":12},"Questionnaire","Questionnaire for the quality of life of ovarian cancer patients. Patients are advised to indicate on a 4-point-Likert scale (1 = not at all; 2 = a little; 3 = quite a bit; 4 = very much) how much a specific issue has occured within a specific time frame and how much this had had an impact on them. Higher scored meaning more impact on quality of life.","Last week or last four weeks",null,{"allocation":13,"interventionModel":13,"interventionModelDescription":13,"primaryPurpose":13,"observationalModel":15,"timePerspective":16,"maskingInfo":13},"COHORT","RETROSPECTIVE","Follows.","Ovarian cancer patients from collaborating centers",[20],{"facility":21,"status":13,"city":22,"state":23,"zip":24,"country":25,"countryCode":26,"cosmosGeoPoint":27,"geoPoint":32,"contacts":33},"Helios University Clinic Wuppertal, University Witten\u002FHerdecke","Wuppertal","North Rhine-Westphalia","42283","Germany","DE",{"type":28,"coordinates":29},"Point",[30,31],7.14816,51.25627,{"lat":31,"lon":30},[34,39],{"name":35,"role":36,"phone":37,"phoneExt":13,"email":38},"Vesna Bjelic-Radisic, Prof","CONTACT","+492028961411","vesna.bjelic-radisic@helios-gesundheit.de",{"name":40,"role":36,"phone":41,"phoneExt":13,"email":42},"Jennifer C. Steinmetz","+49 202 896 1478","jennifer.steinmetz2@helios-gesundheit.de",{"type":44,"investigatorFullName":45,"investigatorTitle":46,"investigatorAffiliation":5,"oldNameTitle":13,"oldOrganization":13},"PRINCIPAL_INVESTIGATOR","Vesna Bjelic-Radisic","Chief of the Breast Unit","100628706","an-international-field-study-of-the-reliability-and-validity-of-a-disease-specific-questionnaire-module-the-qlq-ov28-in-assessing-the-quality-of-life-of-patients-with-ovarian-cancer---phase-iii-100628706",false,"NCT07465133","Updating the EORTC Quality-of-Life Questionnaire for Ovarian Cancer (QLQ-OV38)","The Update of the EORTC QLQ-Ovarial Cancer Module (EORTC-QLQ-OV28) - OV39 Phase III","EORTC QLQ-OV39","Inclusion Criteria:\n\n1. Evidence of localized (FIGO I-II) or advanced ovarian cancer (FIGO II-IV)\n2. Must be able and willing to complete the questionnaires.\n3. Must be able to understand and speak the language in which the patient will complete the questionnaire.\n4. Age \\> 18 years\n\nExclusion Criteria:\n\n* cognitive impairment","FEMALE","18 Years",{"count":58,"type":59},50,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to pre-test the EORTC QLQ-OV39 to identify and resolve potential problems in its administration and to identify missing\u002Fredundant items. A preliminary evaluation of the measurement properties of the module will be carried out.\n\nThe study includes patients with evidence of localized (FIGO I-II) or advanced ovarian cancer (FIGO II-IV) above the age of 18 years.\n\nThe main aims are:\n\n1. To conduct Phase 3a and 3b pre-testing of the preliminary EORTC-QLQ-OV39 Questionnaire to identify and resolve potential problems in its administration and to identify missing\u002Fredundant items according to the updated EORTC QLG Guidelines for Module Development, 5th Edition 2021.(16)\n2. a preliminary assessment of the psychometric properties of the module\n\nParticipants will \\[describe the main tasks participants will be asked to, complete the OV39, C30 and debriefing interviews, as well as questions about their demographics and clinical data.",[63,64],"Ovarian Cancer","Quality of Life",[66,67,64,68],"ovarian cancer","EORTC","EORTC Quality of life group","NOT_YET_RECRUITING","2026-09-15",{"date":72,"type":73},"2026-09-18","ACTUAL",{"date":75,"type":59},"2026-09",{"date":77,"type":59},"2028-12",{"name":5,"class":6},1]